Literature DB >> 24460857

Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP).

R M Talaat1, A M Elmaghraby, S S Barakat, M El-Shahat.   

Abstract

Immune thrombocytopenic purpura (ITP) is acquired autoimmune disease in children characterized by the breakdown of immune tolerance. This work is designed to explore the contribution of different lymphocyte subsets in acute and chronic ITP children. Imbalance in the T helper type 1 (Th1)/Th2 cytokine secretion profile was investigated. The frequency of T (CD3(+), CD4(+), CD8(+)) and B (CD19(+)) lymphocytes, natural killer (NK) (CD16(+) 56(+)) and regulatory T (T(reg)) [CD4(+) CD25(+high) forkhead box protein 3 (FoxP3)(+) ] cells was investigated by flow cytometry in 35 ITP children (15 acute and 20 chronic) and 10 healthy controls. Plasma levels of Th1 cytokines [interferon (IFN-γ) and tumour necrosis factor (TNF-α)] and Th2 [interleukin (IL)-4, IL-6 and IL-10)] cytokines were measured using enzyme-linked immunosorbent assay (ELISA). The percentage of Treg (P < 0·001) and natural killer (NK) (P < 0·001) cells were significantly decreased in ITP patients compared to healthy controls. A negative correlation was reported between the percentage of T(reg) cells and development of acute (r = -0·737; P < 0·01) and chronic (r = -0·515; P < 0·01) disease. All evaluated cytokines (IFN-γ, TNF-α, IL-4, IL-6 and IL-10) were elevated significantly in ITP patients (P < 0·001, P < 0·05, P < 0·05, P < 0·05 and P < 0·001, respectively) compared to controls. In conclusion, our data shed some light on the fundamental role of immune cells and their related cytokines in ITP patients. The loss of tolerance in ITP may contribute to the dysfunction of T(regs). Understanding the role of T cell subsets will permit a better control of autoimmunity through manipulation of their cytokine network.
© 2014 British Society for Immunology.

Entities:  

Keywords:  ITP; NK cells; Th1 and Th2 cells; Treg

Mesh:

Substances:

Year:  2014        PMID: 24460857      PMCID: PMC3992042          DOI: 10.1111/cei.12279

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  72 in total

Review 1.  Regulatory T cells.

Authors:  Claire Thompson; Fiona Powrie
Journal:  Curr Opin Pharmacol       Date:  2004-08       Impact factor: 5.547

2.  [Alterations of CD4+ CD25+ regulatory T cells in patients with idiopathic thrombocytopenic purpura].

Authors:  Yun Ling; Xiang-Shan Cao; Zi-Qiang Yu; Guang-Hua Luo; Xia Bai; Jian Su; Lan Dai; Chang-Geng Ruan
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2007-03

3.  [Role of CD4(+) CD25(high) T cells in the pathogenesis of idiopathic thrombocytopenic purpura].

Authors:  Mi-Mi Shu; Xing-Mei Cao; Wang-Gang Zhang
Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi       Date:  2008-08

4.  Reduced expression of transforming growth factor-β1 and correlated elevation of interleukin-17 and interferon-γ in pediatric patients with chronic primary immune thrombocytopenia (ITP).

Authors:  Jiaan-Der Wang; Te-Kau Chang; Heng-Kuei Lin; Fang-Liang Huang; Chau-Jong Wang; Huei-Jane Lee
Journal:  Pediatr Blood Cancer       Date:  2011-06-30       Impact factor: 3.167

5.  Do natural killer cells regulate B-cell activity?

Authors:  K James; A W Ritchie
Journal:  Immunol Today       Date:  1984-07

6.  Effects of interferon-alpha therapy on immune parameters in immune thrombocytopenic purpura.

Authors:  A R Crossley; A M Dickinson; S J Proctor; J E Calvert
Journal:  Autoimmunity       Date:  1996       Impact factor: 2.815

7.  The levels of IL-17A and of the cytokines involved in Th17 cell commitment are increased in patients with chronic immune thrombocytopenia.

Authors:  Andreia Maria Camargos Rocha; Cláudia Souza; Gifone Aguiar Rocha; Fabrício Freire de Melo; Nelma Cristina Diogo Clementino; Marília Campos Abreu Marino; Adriana Bozzi; Maria Luiza Silva; Olindo Assis Martins Filho; Dulciene Maria Magalhães Queiroz
Journal:  Haematologica       Date:  2011-10       Impact factor: 9.941

Review 8.  The pathogenesis of chronic immune thrombocytopenic purpura.

Authors:  Robert McMillan
Journal:  Semin Hematol       Date:  2007-10       Impact factor: 3.851

Review 9.  Cellular immune mechanisms in autoimmune thrombocytopenic purpura: An update.

Authors:  Malini D Coopamah; M Bernadette Garvey; John Freedman; John W Semple
Journal:  Transfus Med Rev       Date:  2003-01

10.  Evaluation of T cell subsets in myasthenia gravis using anti-T cell monoclonal antibodies.

Authors:  S Berrih; C Gaud; M A Bach; H Le Brigand; J P Binet; J F Bach
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

View more
  22 in total

1.  In vitro TNF blockade enhances ex vivo expansion of regulatory T cells in patients with immune thrombocytopenia.

Authors:  Hui Zhong; James Bussel; Karina Yazdanbakhsh
Journal:  Br J Haematol       Date:  2014-09-24       Impact factor: 6.998

2.  Case Report: ITP Treatment After CAR-T Cell Therapy in Patients With Multiple Myeloma.

Authors:  Mengyi Du; Linlin Huang; Haiming Kou; Chenggong Li; Yu Hu; Heng Mei
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

3.  Imbalanced immune homeostasis in immune thrombocytopenia.

Authors:  Karina Yazdanbakhsh
Journal:  Semin Hematol       Date:  2016-04-07       Impact factor: 3.851

4.  Contributions of T lymphocyte abnormalities to therapeutic outcomes in newly diagnosed patients with immune thrombocytopenia.

Authors:  Zhenhua Zhao; Lei Yang; Guohua Yang; Yun Zhuang; Xifeng Qian; Xin Zhou; Dajiang Xiao; Yunfeng Shen
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

5.  Copy number variants and genetic polymorphisms in TBX21, GATA3, Rorc, Foxp3 and susceptibility to Behcet's disease and Vogt-Koyanagi-Harada syndrome.

Authors:  Dan Liao; Shengping Hou; Jun Zhang; Jing Fang; Yunjia Liu; Lin Bai; Qingfeng Cao; Aize Kijlstra; Peizeng Yang
Journal:  Sci Rep       Date:  2015-04-15       Impact factor: 4.379

6.  Reference Values for a Panel of Cytokinergic and Regulatory Lymphocyte Subpopulations.

Authors:  Vincenzo Sorrenti; Bruno Marenda; Stefano Fortinguerra; Claudia Cecchetto; Roberta Quartesan; Giulia Zorzi; Morena Zusso; Pietro Giusti; Alessandro Buriani
Journal:  Immune Netw       Date:  2016-12-22       Impact factor: 6.303

7.  Associations between TNFSF4, TNFSF8 and TNFSF15 and Behçet's disease but not VKH syndrome in Han Chinese.

Authors:  Yan Jiang; Ling Cheng; Xin Li; Wenke Zhou; Li Zhang
Journal:  Oncotarget       Date:  2017-10-23

8.  Plasma Levels of Interleukin 12 Family Cytokines and Their Relevant Cytokines in Adult Patients with Chronic Immune Thrombocytopenia before and after High-Dose Dexamethasome Treatment.

Authors:  Qingsheng Li; Linjie Zhang; Ruixiang Xia; Qingshu Zeng; Yongqing Wang; Liang Xia; Leiming Xia; Mingzhen Yang
Journal:  Med Princ Pract       Date:  2015-06-23       Impact factor: 1.927

Review 9.  Membranous nephropathy complicated by immune thrombocytopenia treated with low-density lipoprotein apheresis: a case report and literature review.

Authors:  Keitaro Nishizawa; Tomohisa Yamashita; Yayoi Ogawa; Hironori Kobayashi
Journal:  CEN Case Rep       Date:  2021-07-21

10.  Atopic dermatitis and association of risk for primary immune thrombocytopenia and autoimmune diseases among children: A nationwide population-based cohort study.

Authors:  Chang-Ching Wei; Cheng-Li Lin; Te-Chun Shen; Jeng-Dau Tsai
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.